Polypill and Colchicine for Risk Reduction in Atherosclerotic Cardiovascular Disease

NCT06930885 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

7713

Enrollment

OTHER

Sponsor class

Conditions

Atherothrombotic Diseases
Atherosclerotic Cardiovascular Disease (ASCVD)

Interventions

DRUG: Cardiovascular Polypill (Valsartan, Atorvastatin, Aspirin)
DRUG: Colchicine 0.5 mg
DRUG: Usual Care Group
DRUG: Colchicine-placebo 0.5 mg

Sponsor

Hospital do Coracao